Don Ressler: Making Fashion Fun And Stylish

A lot of times when people think of fashion, they may find themselves intimidated and pressured. They look at all of the celebrities and fashion magazines and find out what is being touted as stylish on Instagram. They are also looking at all of the trends. In many cases, they shy away from fashion because they don’t have enough money for the trends. To make things worse, some work hard to save up money only to find out that the item that was trendy then is no longer trendy, and this was only a month or two later. One thing is certain is that trends change a lot.

However, fashion does not have to be intimidating and discouraging, people can actually have fun with fashion when they find the items that they want. For one thing, there are stores and businesses that are making changes to the fashion industry. One of the stores is JustFab which is founded by Don Ressler, and a few other experts in the fashion industry. One thing that JustFab is doing that other fashion retailers are not is basing their sales on what the customers want. In other words, they are not trying to tell customers what to wear. While there are some trendy items in the store, one of the larger factors in the sales is what the customers buy says Don Ressler.

One of the ways that JustFab makes fashion fun is that the company personalizes the products for the customers. To make things better, they provide clothes for a multitude of body types. One thing that the fashion industry and Don Ressler is known for is being almost exclusive in the types of clothes that they showcase. JustFab makes everything diverse with the all-inclusive initiative. This makes it easy for people of all shapes and sizes to find something that looks good on them.

Don Ressler and crew have come across something that is very likable. It is making an impact on the industry and getting people to rethink fashion. People are starting to realize that style and fashion does not have to be so rigid. When people take the time to use their creativity, they could come up with something that is very enjoyable.

Read more:
Kate Hudson’s Fabletics Made Headlines For Its Ad Campaign With a Bleeped Word

JustFab wants to be the next H&M

Stephen Murray’s Legacy

Stephen Murray ran one of the largest companies in the world, CCMP Capital. This company was a management agency that managed a large number of multi-million dollar organizations on Crunchbase. Not only was Stephen Murray the CEO of this company, but he actually helped to found it.

Stephen Murray began his career right after he got his undergraduate degree. He was initially employed as an intern with the company. At the time, it was called Manufacturers Hanover Corporation. This was a bank holding company that managed a number of well known financial institutions. After his internship and completion of his master’s in business administration, Murray became one of their employees.

The company changed a lot over the course of time and changed names, but he remained employed with this same organization. During his career, he began to gain notoriety on nypost.com. In 2006, he began to work with other employees to create CCMP Capital. Shortly after the creation of CCMP Capital, Stephen Murray became it’s chief executive officer. In this position, he helped CCMP Capital to manage a wide variety of companies ranging from hospitals to bargain outlets.

Read more: Exclusive: CCMP Capital CEO Stephen Murray leaves firm

In addition to being a successful CEO, Murray also gave to a number of well known philanthropic organizations. Two of these organizations were the Make-A-Wish Foundation and an organization that provides food to the needy. In addition to philanthropic organizations, he also donated to the Stamford Museum and his two alma matters of Columbia University and Boston College.

Unfortunately, Stephen Murray is no longer with us. Murray passed away a bit over a year ago during April of 2015. However, he had continued to serve an integral role in CCMP Capital up until around one month prior to his death. Many people with the company and outside of the company have fond memories of him. While it was difficult for the company to go on without him, CCMP Capital is still a thriving company. It can be expected that the company he worked to create will go on for many years to come.

Learn more about Stephen Murray: http://www.ccmpcapital.com/team/

Seattle Genetics & It’s Pharmaceutical Drug Pipeline

With all of the advancements in cancer research and drugs, Seattle Genetics stands at the forefront of a very competitive market. The company is looking to widen it’s pipeline of drugs to fight this deadly epidemic while using it’s most commercialized drug, “Adcetris” in many more treatment scenarios. Company (CEO) Clay Siegall stated that the drug is commonly used for fighting Lymphoma and is currently being tested in as many as 70 trials. The final results for all of the trials is expected to make the biggest impact of Seattle Genetics this year. Adcetris is the company’s most successful commercial drug and in the past year has racked up around $226 Million in sales. The company has big things in store and already has 12 other drugs in development in present time.

Company (CEO) and President Clay Siegall has led the way in the fight against cancer and has positioned Seattle Genetics at the apex of the industry. Dr. Siegall has a resume of excellence and has been the proud recipient to a number of industry awards. The company’s(ADC Technology) has generated well over $325 Millionand there are currently more than 20 (ADC’s) in development at present time. Dr. Siegall has been in the industry for many years and has worked with GlaxoSmithKlien, Genentech, and Pfizer.

Clay Siegall and Seattle Genetics has revolutionized the fight against cancer and are continuing to push the company further in the near future. Dr. Siegel currently owns 15 patents and is the author of 70 publications to date. The George Washington University Graduate has guided Seattle Genetics with his strong passion for helping those in need. Seattle Genetics has two drugs for bladder cancer and one for breast cancer that has a large amount of data and that data will be released this year. Clay Siegel and Seattle genetics are the very definition of “the fight against cancer.”

 

Former CCMP Capital CEO Stephen Murray Produced Consistent Gains In Assets Under Management

Stephen Murray’s reputation is still part of daily conversations in the hedge fund industry. Murray did what other hedge fund managers failed to do while he was CEO of CCMP Capital. Murray consistently produced gains in assets under management, and that’s not easy to do, especially in today’s hedge fund market.

But Murray is not participating in the market anymore. Murray passed away in 2015 while he was at the top of the investment game. Murray was the resilient New Yorker that knew how to act around the money people as well as the people that were trying to become money people. Read more: Stephen P. Murray – President @ CCMP Capital Advisors

Hedge fund investors are an elite and closed group, so Murray had to cultivate the investment rookies on his own time, and he did that when an opportunity presented itself. But Murray was tuned into the investment market almost 24/7, and that started after he earned his Master’s degree in Business Administration from Columbia University.

In 1984, Stephen Murray accepted the position as credit trainee, and he felt the rush that only comes when money is exchanged in the millions of dollars instead of in hundreds of dollars. Murray learned how to invest in that Manufacturers Hanover Trust Co position, and he was on his way to becoming a vice-president of the company, and it only took him five years to do that.

When conflict of interest allegations were being thrown around after Manufacturers Hanover Trust Co merged with JP Morgan in 2000, the partners decided to start another investment firm that handled investments in the $100 to $500 million range.

In 2006, the partners picked Murray as CEO of the new company, and they chose an acronym that describes the roots of the company, CCMP. Chemical Venture Partners. Chase Manhattan Bank, Manufacturers Hanover Trust, and JP Morgan are represented in the 4 letter name of Murray’s startup, and by 2007 the investment fund had $3.4 billion in assets under management.

Although Stephen Murray passed away in 2015, some of the strategies he used to produce the gains that the limited partners enjoyed are still being used today. CCMP Capital has not forgotten what Murray did while he was CEO, and the success the firm is having is a tribute to the solid foundation he built when CCMP formed its first fund.

Most hedge funds are just trying to survive in 2016, but CCMP Capital is producing better-than-average gains. The average gains in the hedge fund industry in 2016 are between three and five percent.

Learn more about Stephen Murray CCMP Capital: http://nypost.com/2015/03/13/ccmps-murray-dead-at-52/